Advertisement

Upper extremity transplantation: current concepts and challenges in an emerging field

  • River M. Elliott
  • Scott M. Tintle
  • L. Scott LevinEmail author
Hand and Wrist: Plastics (DT Fufa, Section editor)

Abstract

Loss of an isolated upper limb is an emotionally and physically devastating event that results in significant impairment. Patients who lose both upper extremities experience profound disability that affects nearly every aspect of their lives. While prosthetics and surgery can eventually provide the single limb amputee with a suitable assisting hand, limited utility, minimal haptic feedback, weight, and discomfort are persistent problems with these techniques that contribute to high rates of prosthetic rejection. Moreover, despite ongoing advances in prosthetic technology, bilateral amputees continue to experience high levels of dependency, disability, and distress. Hand and upper extremity transplantation holds several advantages over prosthetic rehabilitation. The missing limb is replaced with one of similar skin color and size. Sensibility, voluntary motor control, and proprioception are restored to a greater degree, and afford better dexterity and function than prosthetics. The main shortcomings of transplantation include the hazards of immunosuppression, the complications of rejection and its treatment, and high cost. Hand and upper limb transplantation represents the most commonly performed surgery in the growing field of Vascularized Composite Allotransplantation (VCA). As upper limb transplantation and VCA have become more widespread, several important challenges and controversies have emerged. These include: refining indications for transplantation, optimizing immunosuppression, establishing reliable criteria for monitoring, diagnosing, and treating rejection, and standardizing outcome measures. This article will summarize the historical background of hand transplantation and review the current literature and concepts surrounding it.

Keywords

Hand transplantation Vascularized composite allotransplantation Hand reconstruction 

Notes

Compliance with Ethics Guidelines

Conflict of Interest

River M. Elliott declares that he has no conflict of interest. Scott M. Tintle declares that he has no conflict of interest. L. Scott Levin declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Grob M, Papadopulos NA, Zimmerman A, et al. The psychological impact of severe hand injury. J Hand Surg Eur. 2008;33:358–62.CrossRefGoogle Scholar
  2. 2.
    Grunert BK, Smith CJ, Devine CA, et al. Early psychological aspects of severe hand injury. J Hand Surg (Br). 1998;13:177–80.CrossRefGoogle Scholar
  3. 3.
    Wright TW, Hagen AD, Wood MB. Prosthetic usage in major upper extremity amputations. J Hand Surg [Am]. 1995;20:619–22.Google Scholar
  4. 4.
    Foroohar A, Elliott RM, Kim TWB, et al. The history and evolution of hand transplantation. Hand Clin. 2011;27:405–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Peacock EE. A review of composite tissue allografts of the digital flexor mechanism. TPS. 1976;8:119–27.Google Scholar
  6. 6.
    Peacock EE. Homologous composite tissue grafts of the digital flexor mechanism in human beings. Transplant Bull. 1960;7:418–21.PubMedCrossRefGoogle Scholar
  7. 7.
    Peacock EE, Madden JW. Human composite flexor tendon allografts. Ann Surg. 1967;166:624–9.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Gilbert R. Transplant is successful with a cadaver forearm. Med Trib Med News. 1964;5:20–3.Google Scholar
  9. 9.
    Benhaim P, Anthony JP, Lin LY, et al. A long-term study of allogenic rat hindlimb transplants immunosuppressed with RS-61443. Transplantation. 1993;56:911–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Ustuner ET, Zdichavsky M, Ren X, et al. Long-term composite tissue allograft survival in a porcine model with cyclosporine/mycophenolate mofetil therapy. Transplantation. 1998;66:1581–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Jones Jr JW, Ustuner ET, Zdichavsky, et al. Long-term survival of an extremity composite tissue allograft with FK506-mycophenolate mofetil therapy. Surgery. 1999;126:384–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Dubernard JM, Owen E, Lefranois N, et al. First human hand transplantation case report. Transpl Int. 2000;13:S521–7.Google Scholar
  13. 13.
    Dubernard JM, Owen E, Herzberg G, et al. Human hand allograft: report on first 6 months. Lancet. 1999;353:1315–20.PubMedCrossRefGoogle Scholar
  14. 14.
    Jones JW, Gruber SA, Barker JH, et al. Successful hand transplantation. One year follow-up. Louisville hand transplant team. N Engl J Med. 2000;343:468–73.PubMedCrossRefGoogle Scholar
  15. 15.
    Breidenbach WC, Gonzales R, Kaufman CL, et al. Outcomes of the first 2 American hand transplants at 8 and 6 years post-transplant. J Hand Surg. 2008;33:1039–47.CrossRefGoogle Scholar
  16. 16.
    Pertuzzo P, Badet C, Gazarian A, et al. Bilateral hand transplantation: six years after the first case. Am J Transplant. 2006;6:1718–24.CrossRefGoogle Scholar
  17. 17.
    Hollenbeck ST, Erdmann D, Levin LS. Current indications for hand and face transplantation. Transplant Proc. 2009;41:495–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Petruzzo P, Lanzetta M, Dubernard JM, et al. The international registry on hand and composite tissue transplantation. Transplantation. 2010;90:1590–4.PubMedCrossRefGoogle Scholar
  19. 19.
    • Petruzzo P, Dubernard JM. The international registry on hand and composite tissue allotransplantation. Clin Transpl. 2011:247–53. Reports the most current aggregate data from the international hand transplant registry. Note that several leading centers do not share data with the registry.Google Scholar
  20. 20.
    Brandacher G, Ninkovic M, Piza-Katzer H, et al. The Innsbruck hand transplant program: update at 8 years after the first hand transplant. Transplant Proc. 2009;41:491–4.PubMedCrossRefGoogle Scholar
  21. 21.
    Cavadas PC, Ibanez J, Thione A, et al. Bilateral trans-humeral arm transplantation: result at 2 years. Am J Transplant. 2011;11:1085–90.PubMedCrossRefGoogle Scholar
  22. 22.
    Stangl MJ, Biemer E, Nerlich A, et al. Three year immunological follow-up of the first bilateral arm transplant world-wide. Transplantation. 2012;94:346.CrossRefGoogle Scholar
  23. 23.
    Jensen SE, Butt Z, Bill A, et al. Quality of life considerations in upper limb transplantation: review and future directions. J Hand Surg [Am]. 2012;37:2126–35.CrossRefGoogle Scholar
  24. 24.
    Murray JE. Organ transplantation (skin, kidney, heart) and the plastic surgeon. Plast Reconstr Surg. 1971;47:425–31.PubMedCrossRefGoogle Scholar
  25. 25.
    Brouha P, Naidu D, Cunningham M, et al. Risk acceptance in composite-tissue allotransplantation reconstructive procedures. Microsurgery. 2006;26:144–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Brandacher G, Gorantla VS, Lee WP. Hand allotransplantation. Semin Plast Surg. 2010;24:11–7.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Schneeberger S, Gorantla VS, Hautz T, et al. Immunosuppression and rejection in human hand transplantation. Transplant Proc. 2009;41:472–5.PubMedCrossRefGoogle Scholar
  28. 28.
    Shores JT, Imbriglia JE, Lee WP. The current state of hand transplantation. J Hand Surg [Am]. 2011;36:1862–7.CrossRefGoogle Scholar
  29. 29.
    Hautz T, Brandacher G, Zelger B, et al. Immunologic aspects and rejection in solid organ vs reconstructive transplantation. Transplantation. 2010;42:3347–53.Google Scholar
  30. 30.
    •• Schneeberger S, Gorantla VS, Brandacher G, et al. Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg. 2013;257:345–51. Outlines the “Pittsburgh Protocol”- a novel and promising method that uses donor bone marrow infusion at the time of transplant in an attempt to induce chimerism in the recipient leading to single drug immunosuppression.PubMedCrossRefGoogle Scholar
  31. 31.
    Starzl TE, Zinkernagel RM. Antigen localization and migration in immunity and tolerance. N Engl J Med. 1998;339:1905–13.PubMedCentralPubMedCrossRefGoogle Scholar
  32. 32.
    Starzl TE, Murase N, Abu-Elmagd, et al. Tolerogenic immunosuppression for organ transplantation. Lancet. 2003;361:1502–10.PubMedCentralPubMedCrossRefGoogle Scholar
  33. 33.
    Fontes P. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet. 1994;344:151–5.PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Ciancio G, Miller J, Garcia-Morales RO, et al. Six-year clinical effect of donor bone marrow infusions in renal transplant patients. Transplantation. 2001;71:827–35.PubMedCrossRefGoogle Scholar
  35. 35.
    Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature. 1984;307:168–70.PubMedCrossRefGoogle Scholar
  36. 36.
    Wu S, Xu H, Ravindra K, et al. Composite tissue allotransplantation: past, present, and future-the history and expanding applications of CTA as a new frontier in transplantation. Transplant Proc. 2009;41:463–5.PubMedCentralPubMedCrossRefGoogle Scholar
  37. 37.
    Birch R. Nerve repair. In: Wolfe SW, Hotchkiss RN, Pederson WC, Kozin SH, editors. Green’s operative hand surgery. Philadelphia: Elsevier; 2011. p. 1035–74.CrossRefGoogle Scholar
  38. 38.
    Tanaka K, Fujita N, Higashi Y, et al. Neuroprotective and antioxidant properties of FKBP-binding immunophilin ligands are independent on the FKBP12 pathway in human cells. Neurosci Lett. 2002;330:147–50.PubMedCrossRefGoogle Scholar
  39. 39.
    Yan Y, Sun HH, Hunter DA, et al. Efficacy of short-term FK506 administration on accelerating nerve regeneration. Neurorehabil Neural Repair. 2012;26:570–80.PubMedCrossRefGoogle Scholar
  40. 40.
    Moore AM, Ray WZ, Chenard KE, et al. Nerve allotransplantation as it pertains to composite tissue transplantation. Hand. 2009;4:239–44.PubMedCentralPubMedCrossRefGoogle Scholar
  41. 41.
    Mackinnon SE, Doolabh VB, Novack CB, et al. Clinical outcome following nerve allograft transplantation. Plast Reconstr Surg. 2001;107:1419–29.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • River M. Elliott
    • 1
  • Scott M. Tintle
    • 2
  • L. Scott Levin
    • 3
    Email author
  1. 1.The Curtis National Hand CenterBaltimoreUSA
  2. 2.Department of Orthopaedic SurgeryWalter Reed National Military Medical CenterBethesdaUSA
  3. 3.Department of Orthopaedic SurgeryHospital of the University of PennsylvaniaPhiladelphiaUSA

Personalised recommendations